WCLC 2025 - Posters & ePosters-P3.12.65 First-Line Osimertinib ± Platinum-Pemetrexed in EGFR-Mutated Advanced NSCLC: FLAURA2 Clinical Outcomes by EGFRm Subtype

P3.12.65 First-Line Osimertinib ± Platinum-Pemetrexed in EGFR-Mutated Advanced NSCLC: FLAURA2 Clinical Outcomes by EGFRm Subtype

Asset Subtitle

Samreen Ahmed

Meta Tag

Speaker Samreen Ahmed

Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy